Table 2.
Percutaneous transsplenic varices embolization before and after interventional treatment
| Preintervention (n = 29) | Postintervention (n = 26) |
P value | |
|---|---|---|---|
| Age | 75 ± 8.2 | 74 ± 7.1 | 0.842 |
| Gender (female/male) | 9/20 | 9/17 | 0.777 |
| Child-Pugh (A/B/C) | 9/14/6 | 6/14/6 | 0.803 |
| ALT (IU/L) | 20.0 ± 11.4 | 21.3 ± 11.3 | 0.672 |
| AST (IU/L) | 24.0 ± 8.9 | 22.6 ± 8.7 | 0.575 |
| Platelet count | 178 ± 61.6 | 162 ± 45 | 0.277 |
| Total bilirubin (μmol/L) | 23.0 ± 13.1 | 28.1 ± 14.0 | 0.186 |
| Prothrombin time (s) | 13.6 ± 1.7 | 13.2 ± 2.5 | 0.595 |
| Albumin (g/L) | 35.6 ± 3.3 | 34.5 ± 3.9 | 0.261 |
| Coronary vein (stage 1/2/3/4) | 0/7/19/3 | 4/22/0/0 | < 0.001 |
| Esophageal vein (stage 1/2/3/4) | 6/12/7/4 | 9/17/0/0 | 0.006 |
| Paraesophageal vein (stage 1/2/3/4) | 10/10/5/4 | 17/9/0/0 | 0.013 |
| Gastroepiploic vein (stage 1/2/3/4) | 10/13/4/2 | 8/13/5/0 | 0.537 |
| Short gastric vein (stage 1/2/3/4) | 15/14/0/0 | 11/11/4/0 | 0.089 |
| Perisplenic vein (stage 1/2/3/4) | 20/9/0/0 | 11/9/6/0 | 0.014 |
| Gastrorenal vein (stage 1/2/3/4) | 10/17/2/0 | 8/13/5/0 | 0.390 |
| Splenorenal vein (stage 1/2/3/4) | 15/13/1/0 | 9/16/1/0 | 0.437 |
| RPV (stage 1/2/3/4) | 19/10/0/0 | 15/11/0/0 | 0.550 |
| Mesenteric vein (stage 1/2/3/4) | 22/6/1/0 | 16/9/1/0 | 0.500 |
| Omental vein (stage 1/2/3/4) | 17/12/0/0 | 12/13/1/0 | 0.412 |
| Paraumbilical vein (stage 1/2/3/4) | 19/6/3/1 | 14/9/2/1 | 0.706 |
| Abdominal-wall vein (stage 1/2/3/4) | 17/10/1/1 | 17/8/1/0 | 0.786 |
ALT = alanine aminotransferase; AST = aspartate aminotransferase; RPV = retroperitoneal paravertebral vein.